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SHORT COMMUNICATION Open Access
Perfect Storm:
COVID-19 Associated Cardiac Injury and
Implications for Neurological Disorders
Catherine Ruth Jutzeler,1,2,*,** Thomas Edward Nightingale,3,4,** Andrei Vasilievich Krassioukov,4 and Matthias Walter4,5
Abstract
Coronavirus disease 2019 (COVID-19) can lead to considerable lung damage and even death. Less is known
about the effects of COVID-19 on the cardiovascular system. In their recent JAMA Cardiology article, Shi and col-
leagues reported an association between cardiac injury and higher risk of in-hospital mortality in patients with
COVID-19. Approximately 20% (82 patients) of the study cohort presented with a cardiac injury. The investigators
identified cardiac injury as an independent risk factor of mortality during hospitalization (52% with cardiac injury
vs. 5% without cardiac injury, p < 0.001). Consequently, their findings are highly relevant for patients with pre-
existing cardiovascular and cerebrovascular diseases. Among those are patients with neurological disorders.
There is a considerable prevalence of myocardial injury in patients with acute neurological illness, which appears
to adversely affect prognosis. Individuals with an underlying neurological disorder are particularly vulnerable to
increased cardio-cerebrovascular disease risk due to physical limitations and the pathophysiology of their con-
dition. Thus, we would like to specifically highlight the attention of health care professionals treating patients
with pervasive neurological disorders to their potentially elevated risk of poorer COVID-19 related outcomes.
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Introduction
Viral infections, such as coronavirus disease 2019
(COVID-19), can trigger respiratory infections that
may lead to considerable lung damage and even death.
Less is known about the effects of the severe acute respi-
ratory syndrome coronavirus 2 (SARS-CoV-2), the caus-
ative agent of COVID-19, on the cardiovascular system.
In their recent JAMA Cardiology article, Shi and col-
leagues shed light on the association between cardiac in-
jury and a higher risk of in-hospital mortality in patients
with laboratory-confirmed COVID-19.1 The investiga-
tors defined cardiac injury as high-sensitivity troponin I
(hs-TNI) above the 99th-percentile upper reference
limit. For patients to be included in the analysis, labora-
tory confirmation, medical information, and core exam-
ination results were required.
Of 1004 hospitalized patients, only 416 (median age,
64 years; 51% women) were included in the analysis.
Overall, fever was the most common symptom (334 pa-
tients [80%]) followed by cough (144 patients [35%]) and
shortness of breath (117 patients [28%]). Approximately
20% (82 patients) of the study cohort presented with a
cardiac injury. The investigators identified cardiac injury
as an independent risk factor of mortality during
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hospitalization (52% with cardiac injury vs. 5% without
cardiac injury, p < 0.001). Additionally, a greater pro-
portion of patients with cardiac injury required me-
chanical ventilation (i.e., non-invasive [46 vs. 4%,
p < 0.001] and invasive [22 vs. 4%, p < 0.001]) and in-
hospital complications (e.g., acute respiratory distress
syndrome [59 vs. 15%, p < 0.001], acute kidney injury
(9 vs. <1%, p < 0.001]) were more common. Lastly, histo-
ries of hypertension (60 vs. 23%, p < 0.001), coronary
heart disease (29 vs. 6%, p < 0.001), chronic heart failure
(15 vs. 2%, p < 0.001), and cerebrovascular disease (16 vs.
3%, p < 0.001) were more common among patients with
cardiac injury.
Although the study conveys important information
regarding the association between cardiac injury and dis-
ease outcome in patients with COVID-19, it comes with
major limitations that need to be considered when inter-
preting the results. First, the authors excluded over 588
patients of the initial cohort, of whom 39% were ex-
cluded because of missing cardiac biomarkers, including
values of hs-TNI and creatine kinase myocardial band.
This is problematic as patients with pre-existing cardio-
vascular conditions are more likely to get tested for car-
diac biomarkers, which can lead to a selection bias.
Second, patients with cardiac injury were older (median
age, 74 vs. 60 years, p < 0.001); had higher levels of leu-
kocytes, procalcitonin, C-reactive protein, and creati-
nine; and had lower levels of lymphocytes and platelets
compared with patients without cardiac injury.
Despite these limitations, the study provides impor-
tant evidence that COVID-19 can have detrimental ef-
fects on the heart, even in patients without pre-existing
heart conditions. Importantly, these findings are not
unique to COVID-19. Other viral infections, such as in-
fluenza A (H1N1)2 and SARS-CoV-1,3 have also been
reported to worsen pre-existing cardiovascular diseases
and cause new ones in otherwise healthy individuals.
Consequently, the findings of Shi and colleagues are
highly relevant for patients with pre-existing cardiovas-
cular and cerebrovascular diseases. Among those are
patients with neurological disorders, including individ-
uals with spinal cord injury,4 traumatic brain injury,5
multiple sclerosis,6 Alzheimer’s disease,7 and Parkin-
son’s disease.8
There is a considerable prevalence of myocardial in-
jury in patients with acute neurological illness, which
appears to adversely affect prognosis.9 Individuals
with an underlying neurological disorder are particu-
larly vulnerable to increased cardio-cerebrovascular
disease risk due to physical limitations and the patho-
physiology of their condition. For example, individuals
with spinal cord injury often present with chronic in-
flammation and a degree of immune impairment, either
as a result of reduced physical activity or autonomic
nervous system dysfunction causing immunodeficiency
through diminished innervation of lymphoid organs or
associated endocrine disorders.10 Thus, we would like to
specifically highlight the attention of health care profes-
sionals treating patients with pervasive neurological
disorders to their potentially elevated risk of poorer
COVID-19 related outcomes. It is of utmost impor-
tance that the practice of social distancing is empha-
sized in these population groups and vulnerable
individuals adhere to self-isolation practices to mini-
mize transmission of the disease. These practices are
particularly relevant for individuals with neurological
disorders given the increased prevalence and constella-
tion of risk factors identified by Shi and colleagues as
important for the prognosis of COVID-19 patients.
Conversely, it remains to be seen what impact
COVID-19 has on the progression of existing cardiovas-
cular disease in at-risk individuals with neurological dis-
orders, particularly as other viral infections have been
shown to worsen pre-existing cardiovascular diseases
and cause new ones in otherwise healthy individuals.
Therefore, future research is necessary to investigate to
what extent testing positive for COVID-19 exacerbates
pre-existing conditions or predisposes individuals with
neurological disorders to developing new ones.
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